These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 11748645
1. Expression and localization of HGF and met in Wilms' tumours. Alami J, Williams BR, Yeger H. J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645 [Abstract] [Full Text] [Related]
2. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Pritchard-Jones K, Fleming S. Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569 [Abstract] [Full Text] [Related]
3. Derivation and characterization of a Wilms' tumour cell line, WiT 49. Alami J, Williams BR, Yeger H. Int J Cancer; 2003 Nov 10; 107(3):365-74. PubMed ID: 14506735 [Abstract] [Full Text] [Related]
4. Nuclear accumulation of beta-catenin protein in Wilms' tumours. Koesters R, Niggli F, von Knebel Doeberitz M, Stallmach T. J Pathol; 2003 Jan 10; 199(1):68-76. PubMed ID: 12474228 [Abstract] [Full Text] [Related]
5. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas. Choi JH, Lee SH, Lee HM, Lee SH, Jung HH, Choi J, Lim HW, Lee SW, Kang SM. Acta Otolaryngol; 2006 Jul 10; 126(7):724-9. PubMed ID: 16803712 [Abstract] [Full Text] [Related]
6. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, Demetris AJ. Hepatology; 1998 Nov 10; 28(5):1260-8. PubMed ID: 9794910 [Abstract] [Full Text] [Related]
7. Expression of hepatocyte growth factor and its receptor met in Wilms' tumors and nephrogenic rests reflects their roles in kidney development. Vuononvirta R, Sebire NJ, Messahel B, Perusinghe N, Reis-Filho JS, Pritchard-Jones K, Vujanic GM, Jones C. Clin Cancer Res; 2009 Apr 15; 15(8):2723-30. PubMed ID: 19318497 [Abstract] [Full Text] [Related]
8. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma. Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ. Clin Cancer Res; 2000 Nov 15; 6(11):4265-71. PubMed ID: 11106242 [Abstract] [Full Text] [Related]
9. Expression of WT1 protein in fetal kidneys and Wilms tumors. Grubb GR, Yun K, Williams BR, Eccles MR, Reeve AE. Lab Invest; 1994 Oct 15; 71(4):472-9. PubMed ID: 7967503 [Abstract] [Full Text] [Related]
10. C-kit protein expression in Wilms' tumour: an immunohistochemical study. Giordano G, Campanini N, Rocco A, Donofrio V, Bertolini P, Falleti J, Pettinato G. Eur J Surg Oncol; 2009 Jun 15; 35(6):629-35. PubMed ID: 19010635 [Abstract] [Full Text] [Related]
11. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue. Lindemann K, Resau J, Nährig J, Kort E, Leeser B, Annecke K, Welk A, Schäfer J, Vande Woude GF, Lengyel E, Harbeck N. Histopathology; 2007 Jul 15; 51(1):54-62. PubMed ID: 17593080 [Abstract] [Full Text] [Related]
12. Molecular and cellular biology of Wilms' tumour. Maitland NJ, Brown KW, Poirier V, Shaw AP, Williams J. Anticancer Res; 1989 Jul 15; 9(5):1417-26. PubMed ID: 2556071 [Abstract] [Full Text] [Related]
13. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes. Yeger H, Cullinane C, Flenniken A, Chilton-MacNeil S, Campbell C, Huang A, Bonetta L, Coppes MJ, Thorner P, Williams BR. Cell Growth Differ; 1992 Dec 15; 3(12):855-64. PubMed ID: 1335280 [Abstract] [Full Text] [Related]
15. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour. Juszkiewicz P, Tuziak T, Zbisławski W, Liebhard M, Chosia M. Pol J Pathol; 1997 Dec 15; 48(2):113-9. PubMed ID: 9278108 [Abstract] [Full Text] [Related]
16. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J. Vet Pathol; 2009 Sep 15; 46(5):869-77. PubMed ID: 19429984 [Abstract] [Full Text] [Related]
17. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression. Tretiakova M, Turkyilmaz M, Grushko T, Kocherginsky M, Rubin C, Teh B, Yang XJ. J Clin Pathol; 2006 Dec 15; 59(12):1272-7. PubMed ID: 16556665 [Abstract] [Full Text] [Related]
18. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Van den Heuvel MM, Noordzij MA, Nijman RJ, Soliman EH, van Steenbrugge GJ. Br J Cancer; 2001 Nov 16; 85(10):1557-63. PubMed ID: 11720445 [Abstract] [Full Text] [Related]
19. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE. Pediatr Dev Pathol; 2004 Nov 16; 7(2):125-37. PubMed ID: 14994125 [Abstract] [Full Text] [Related]
20. Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development. Ricci G, Catizone A, Galdieri M. J Endocrinol; 2006 Dec 16; 191(3):559-70. PubMed ID: 17170214 [Abstract] [Full Text] [Related] Page: [Next] [New Search]